• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过氧化物酶体增殖物激活受体基因多态性在2型糖尿病和代谢综合征中的作用。

Role of peroxisome proliferator-activated receptors gene polymorphisms in type 2 diabetes and metabolic syndrome.

作者信息

Dong Chen, Zhou Hui, Shen Chong, Yu Lu-Gang, Ding Yi, Zhang Yong-Hong, Guo Zhi-Rong

机构信息

Chen Dong, Hui Zhou, Yong-Hong Zhang, Zhi-Rong Guo, Department of Epidemiology, School of Public Health, Soochow University, Suzhou 215123, Jiangsu Province, China.

出版信息

World J Diabetes. 2015 May 15;6(4):654-61. doi: 10.4239/wjd.v6.i4.654.

DOI:10.4239/wjd.v6.i4.654
PMID:25987964
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4434087/
Abstract

Metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM) are the serious public health problems worldwide. Moreover, it is estimated that MetS patients have about five-fold greater risk of the T2DM development compared with people without the syndrome. Peroxisome proliferator-activated receptors are a subgroup of the nuclear hormone receptor superfamily of ligand-activated transcription factors which play an important role in the pathogenesis of MetS and T2DM. All three members of the peroxisome proliferator-activated receptor (PPAR) nuclear receptor subfamily, PPARα, PPARβ/δ and PPARγ are critical in regulating insulin sensitivity, adipogenesis, lipid metabolism, and blood pressure. Recently, more and more studies indicated that the gene polymorphism of PPARs, such as Leu(162)Val and Val(227)Ala of PPARα, +294T > C of PPARβ/δ, Pro(12)Ala and C1431T of PPARγ, are significantly associated with the onset and progressing of MetS and T2DM in different population worldwide. Furthermore, a large body of evidence demonstrated that the glucose metabolism and lipid metabolism were influenced by gene-gene interaction among PPARs genes. However, given the complexity pathogenesis of metabolic disease, it is unlikely that genetic variation of a single locus would provide an adequate explanation of inter-individual differences which results in diverse clinical syndromes. Thus, gene-gene interactions and gene-environment interactions associated with T2DM and MetS need future comprehensive studies.

摘要

代谢综合征(MetS)和2型糖尿病(T2DM)是全球严重的公共卫生问题。此外,据估计,与无该综合征的人相比,MetS患者发生T2DM的风险大约高五倍。过氧化物酶体增殖物激活受体是配体激活转录因子核激素受体超家族的一个亚组,在MetS和T2DM的发病机制中起重要作用。过氧化物酶体增殖物激活受体(PPAR)核受体亚家族的所有三个成员,即PPARα、PPARβ/δ和PPARγ,在调节胰岛素敏感性、脂肪生成、脂质代谢和血压方面都至关重要。最近,越来越多的研究表明,PPARs的基因多态性,如PPARα的Leu(162)Val和Val(227)Ala、PPARβ/δ的+294T > C、PPARγ的Pro(12)Ala和C1431T,在全球不同人群中与MetS和T2DM的发生及进展显著相关。此外,大量证据表明,PPARs基因之间的基因-基因相互作用会影响葡萄糖代谢和脂质代谢。然而,鉴于代谢性疾病发病机制的复杂性,单个位点的基因变异不太可能充分解释导致不同临床综合征的个体间差异。因此,与T2DM和MetS相关的基因-基因相互作用和基因-环境相互作用需要未来进行全面研究。

相似文献

1
Role of peroxisome proliferator-activated receptors gene polymorphisms in type 2 diabetes and metabolic syndrome.过氧化物酶体增殖物激活受体基因多态性在2型糖尿病和代谢综合征中的作用。
World J Diabetes. 2015 May 15;6(4):654-61. doi: 10.4239/wjd.v6.i4.654.
2
PPARs and the kidney in metabolic syndrome.过氧化物酶体增殖物激活受体与代谢综合征中的肾脏
Am J Physiol Renal Physiol. 2008 May;294(5):F1032-47. doi: 10.1152/ajprenal.00152.2007. Epub 2008 Jan 30.
3
New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).2型糖尿病和代谢综合征治疗的新方法(聚焦于一种新型胰岛素增敏剂)
Acta Med Indones. 2006 Jul-Sep;38(3):160-6.
4
Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease.过氧化物酶体增殖物激活受体、代谢综合征与心血管疾病
Future Cardiol. 2010 Sep;6(5):657-91. doi: 10.2217/fca.10.86.
5
Differential regulation of macrophage peroxisome proliferator-activated receptor expression by glucose : role of peroxisome proliferator-activated receptors in lipoprotein lipase gene expression.葡萄糖对巨噬细胞过氧化物酶体增殖物激活受体表达的差异调节:过氧化物酶体增殖物激活受体在脂蛋白脂肪酶基因表达中的作用
Arterioscler Thromb Vasc Biol. 2000 Jan;20(1):104-10. doi: 10.1161/01.atv.20.1.104.
6
Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels.过氧化物酶体增殖物激活受体 (PPARs) 在细胞和整体水平上的多方面作用。
Swiss Med Wkly. 2010 Sep 15;140:w13071. doi: 10.4414/smw.2010.13071. eCollection 2010.
7
Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.过氧化物酶体增殖物激活受体与动脉粥样硬化形成:血管细胞中基因表达的调节因子
Circ Res. 2004 May 14;94(9):1168-78. doi: 10.1161/01.RES.0000127122.22685.0A.
8
Pleiotropic Actions of Peroxisome Proliferator-Activated Receptors (PPARs) in Dysregulated Metabolic Homeostasis, Inflammation and Cancer: Current Evidence and Future Perspectives.过氧化物酶体增殖物激活受体(PPARs)在代谢稳态失调、炎症和癌症中的多效性作用:当前证据与未来展望
Int J Mol Sci. 2016 Jun 24;17(7):999. doi: 10.3390/ijms17070999.
9
Novel approach to treat insulin resistance, type 2 diabetes, and the metabolic syndrome: simultaneous activation of PPARalpha, PPARgamma, and PPARdelta.治疗胰岛素抵抗、2型糖尿病和代谢综合征的新方法:同时激活过氧化物酶体增殖物激活受体α、γ和δ
Curr Diabetes Rev. 2005 Aug;1(3):299-307. doi: 10.2174/157339905774574365.
10
[PPAR family and its relationship to metabolic syndrome].[过氧化物酶体增殖物激活受体家族及其与代谢综合征的关系]
Sheng Li Ke Xue Jin Zhan. 2005 Jan;36(1):6-12.

引用本文的文献

1
PPARs in Clinical Experimental Medicine after 35 Years of Worldwide Scientific Investigations and Medical Experiments.经过 35 年的全球科学研究和医学实验,PPARs 在临床实验医学中的应用。
Biomolecules. 2024 Jul 1;14(7):786. doi: 10.3390/biom14070786.
2
Unveiling the Chemistry of Citrus Peel: Insights into Nutraceutical Potential and Therapeutic Applications.揭示柑橘皮的化学性质:对营养保健潜力和治疗应用的见解。
Foods. 2024 May 27;13(11):1681. doi: 10.3390/foods13111681.
3
Peroxisome Proliferator-Activated Receptor α and γ Gene Polymorphisms among South Indian Patients with Diabetic Dyslipidaemia.南印度糖尿病血脂异常患者过氧化物酶体增殖物激活受体α和γ基因多态性
Indian J Endocrinol Metab. 2023 Mar-Apr;27(2):118-126. doi: 10.4103/ijem.ijem_451_22. Epub 2023 Apr 14.
4
NGS Sequencing Reveals New Gene Variants Potentially Associated with MetS and/or T2DM Risk in the Polish Population-A Preliminary Study.二代测序揭示新的基因变异,可能与波兰人群的代谢综合征和/或 2 型糖尿病风险相关——一项初步研究。
Genes (Basel). 2023 Mar 24;14(4):789. doi: 10.3390/genes14040789.
5
Association of main meal quality index with the odds of metabolic syndrome in Iranian adults: a cross-sectional study.伊朗成年人主餐质量指数与代谢综合征几率的关联:一项横断面研究。
BMC Nutr. 2023 Mar 21;9(1):55. doi: 10.1186/s40795-023-00711-2.
6
Nuclear Receptors in Myocardial and Cerebral Ischemia-Mechanisms of Action and Therapeutic Strategies.核受体在心肌和脑缺血中的作用机制及治疗策略。
Int J Mol Sci. 2021 Nov 15;22(22):12326. doi: 10.3390/ijms222212326.
7
Effects of FTO and PPARγ variants on intrauterine growth restriction in a Brazilian birth cohort.FTO 和 PPARγ 变异对巴西出生队列中宫内生长受限的影响。
Braz J Med Biol Res. 2021 Mar 10;54(1):e10465. doi: 10.1590/1414-431X202010465. eCollection 2021.
8
Beneficial Effects of Echinacoside on Diabetic Cardiomyopathy in Diabetic Mice.松果菊苷对糖尿病小鼠糖尿病心肌病的有益作用。
Drug Des Devel Ther. 2020 Dec 18;14:5575-5587. doi: 10.2147/DDDT.S276972. eCollection 2020.
9
Genetic variants associated with exercise performance in both moderately trained and highly trained individuals.与中等训练和高训练个体的运动表现相关的遗传变异。
Mol Genet Genomics. 2020 Mar;295(2):515-523. doi: 10.1007/s00438-019-01639-8. Epub 2020 Jan 2.
10
PPARα-Mediated Positive-Feedback Loop Contributes to Cold Exposure Memory.过氧化物酶体增殖物激活受体α(PPARα)介导的正反馈回路有助于冷暴露记忆。
Sci Rep. 2019 Mar 14;9(1):4538. doi: 10.1038/s41598-019-40633-3.

本文引用的文献

1
Revisiting PPARγ as a target for the treatment of metabolic disorders.重新审视 PPARγ 作为治疗代谢紊乱的靶点。
BMB Rep. 2014 Nov;47(11):599-608. doi: 10.5483/bmbrep.2014.47.11.174.
2
Association of peroxisome proliferator-activated receptor-delta polymorphisms with sugar metabolism indices and tumor necrosis factor alpha level.过氧化物酶体增殖物激活受体δ基因多态性与糖代谢指标及肿瘤坏死因子α水平的关联
Genet Mol Res. 2014 Jul 7;13(3):5088-93. doi: 10.4238/2014.July.7.1.
3
Prevalence, components and associated demographic and lifestyle factors of the metabolic syndrome in type 2 diabetes mellitus.2型糖尿病患者中代谢综合征的患病率、组成成分及相关人口统计学和生活方式因素
J Diabetes Metab Disord. 2014 Jul 15;13:80. doi: 10.1186/2251-6581-13-80. eCollection 2014.
4
Analysis on the association between PPARα/γ polymorphisms and lipoprotein(a) in a Chinese Han population.中国汉族人群中PPARα/γ基因多态性与脂蛋白(a)的相关性分析。
Mol Genet Genomics. 2014 Oct;289(5):981-7. doi: 10.1007/s00438-014-0866-9. Epub 2014 Jun 1.
5
PPARδ activation attenuates hepatic steatosis in Ldlr-/- mice by enhanced fat oxidation, reduced lipogenesis, and improved insulin sensitivity.过氧化物酶体增殖物激活受体δ(PPARδ)激活通过增强脂肪氧化、减少脂肪生成和改善胰岛素敏感性来减轻Ldlr-/-小鼠的肝脏脂肪变性。
J Lipid Res. 2014 Jul;55(7):1254-66. doi: 10.1194/jlr.M046037. Epub 2014 May 26.
6
Effect of the PPARγ C161T gene variant on serum lipids in ischemic stroke patients with and without type 2 diabetes mellitus.PPARγ C161T基因变异对合并或未合并2型糖尿病的缺血性脑卒中患者血脂的影响。
J Mol Neurosci. 2014 Dec;54(4):730-8. doi: 10.1007/s12031-014-0326-3. Epub 2014 May 21.
7
Peroxisome proliferator activated receptor γ2 gene Pro12Ala gene polymorphism in type 2 diabetes and its relationship with diabetic nephropathy.过氧化物酶体增殖物激活受体γ2基因Pro12Ala基因多态性与2型糖尿病及其与糖尿病肾病的关系。
Clin Lab. 2014;60(5):743-9. doi: 10.7754/clin.lab.2013.130443.
8
Application of the back-error propagation artificial neural network (BPANN) on genetic variants in the PPAR-γ and RXR-α gene and risk of metabolic syndrome in a Chinese Han population.反向传播人工神经网络(BPANN)在中国汉族人群中PPAR-γ和RXR-α基因遗传变异与代谢综合征风险的应用。
J Biomed Res. 2014 Mar;28(2):114-22. doi: 10.7555/JBR.27.20120061. Epub 2013 Mar 20.
9
Effect of obesity on the association between common variations in the PPAR gene and C-reactive protein level in Chinese Han population.肥胖对中国汉族人群中PPAR基因常见变异与C反应蛋白水平之间关联的影响。
Endocrine. 2015 Feb;48(1):195-202. doi: 10.1007/s12020-014-0218-x. Epub 2014 Mar 7.
10
Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications--a review.过氧化物酶体增殖物激活受体及其配体:营养与临床意义——综述
Nutr J. 2014 Feb 14;13:17. doi: 10.1186/1475-2891-13-17.